Huasong Zeng
发表
Palmitoylation restricts SQSTM1/p62-mediated autophagic degradation of NOD2 to modulate inflammation
J. Cui,
Lingli Zhou,
Liqiu Wang,
2022,
Cell Death & Differentiation.
W. Lu,
K. Chiu,
M. Hong,
2020,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
R. Chen,
Wanfu Xu,
C. Wong,
2022,
Mediators of inflammation.
S. Gong,
Wanyan Deng,
Huasong Zeng,
2020,
Acta biochimica et biophysica Sinica.
Maoyi Yang,
Yi Chen,
S. Gong,
2022,
Frontiers in Microbiology.
M. Hong,
C. Wong,
P. Wei,
2021,
Clinical and translational medicine.
Huiying Liang,
Hongwei Li,
Ying Xie,
2019,
Front. Pharmacol..
Song Zhang,
Huasong Zeng,
Yanhao Lin,
2020
.
Zichuan Xu,
Xia Gao,
Huixian Li,
2022,
Pharmacotherapy.
F. Fu,
Huasong Zeng,
Xiaolan Mo,
2023,
Frontiers in Pediatrics.
W. Lu,
M. Hong,
C. Wong,
2020,
Journal of orthopaedic translation.
Qi Ren,
Huasong Zeng,
Shengyou Yu,
2022,
International journal of medical sciences.
Z. Cai,
Song Zhang,
Huasong Zeng,
2021,
Pediatric Rheumatology.
Huiying Liang,
Guangfeng Lin,
Ying Xie,
2020,
Frontiers in Pharmacology.
Huasong Zeng,
Xiangyuan Chen,
Dongsheng Lian,
2023,
Frontiers in Cell and Developmental Biology.
Guangxun Meng,
Jiaochan Han,
Zhe Cai,
2023,
International journal of molecular sciences.
N. Ruperto,
Pei-Fen Liao,
Huasong Zeng,
2023,
International Journal of Rheumatic Diseases.
J. Cui,
Lingli Zhou,
Shouheng Jin,
2022,
Autophagy.
Huasong Zeng,
Song Zhang,
Xue Li,
2024,
Pediatric rheumatology online journal.